Efficacy and safety of treating patients with refractory schizophrenia with antipsychotic medication and adjunctive electroconvulsive therapy: a systematic review and meta-analysis.

Wenzheng Wang, Chengcheng Pu, Jiangling Jiang, Xinyi Cao, Jijun Wang, Min Zhao, Chunbo LiPubMed 2015 · DOI

Abstract

There are very few high quality randomized controlled clinical trials about the combination of antipsychotic medications and ECT in the treatment of refractory schizophrenia. This meta-analysis found that the combination of antipsychotic medications and ECT could improve psychiatric symptoms in patients with refractory schizophrenia, but the incomplete methodological information provided for most of the studies, publication bias (favoring studies with better outcomes in the combined treatment group), and the low quality of evidence about adverse outcomes, cognitive impairment, and overall functioning raise questions about the validity of the results.
BibTeX
@inproceedings{wang2015efficacy,
  author = {Wenzheng Wang and Chengcheng Pu and Jiangling Jiang and Xinyi Cao and Jijun Wang and Min Zhao and Chunbo Li},
  title = {{Efficacy and safety of treating patients with refractory schizophrenia with antipsychotic medication and adjunctive electroconvulsive therapy: a systematic review and meta-analysis.}},
  booktitle = {PubMed},
  year = {2015},
  doi = {10.11919/j.issn.1002-0829.215093},
}

Loading related content...

Figure